Commune · Savoirs
Pyrilutamide
Chemical compound
Pyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of androgenic alopecia (pattern hair loss) and acne. The drug is being developed by Suzhou Kintor Pharmaceuticals.
Sur Wikipédia
Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.
Pyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of androgenic alopecia (pattern hair loss) and acne. The drug is being developed by Suzhou Kintor Pharmaceuticals. As of February 2025, it is in phase 3 clinical trials for androgenic alopecia and phase 2 trials for acne. The drug was also under development for the treatment of diabetic foot ulcers, but development for this indication was discontinued.
Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Fluridil-god (CC BY-SA 4.0) ·
